The pathophysiology of Sandimmune (cyclosporine) in man and animals
- PMID: 2242327
- DOI: 10.1007/BF00869843
The pathophysiology of Sandimmune (cyclosporine) in man and animals
Abstract
Part I: The side-effects of Sandimmune that have been of most significance clinically are renal dysfunction, renal vascular damage and arterial hypertension. To examine the nature and the origin of such effects, the actions of Sandimmune on the renal tubule, the renal vessels and systemic vessels have been analyzed. To evaluate whether common vasoconstrictory systems may be involved, changes in the renin-angiotensin-aldosterone system and prostaglandin-thromboxane system have been assessed. Comparison between animal and human data obtained in vivo and in vitro shows the actions of Sandimmune on the renal tubule to be modest and involve only a few specific effects. The major action of Sandimmune is on the vessels, vasoconstriction being the major cause of renal dysfunction and also the cause of arterial hypertension. Neither the circulating renin-angiotension-aldosterone system nor the prostaglandin-thromboxane system is clearly responsible for vasoconstriction. Although not itself a vasoconstrictor, Sandimmune seems to modulate the constrictory and dilatory response to other agents in several vascular beds.
Similar articles
-
Cyclosporine and the renin-angiotensin system.Kidney Int Suppl. 1991 Jun;32:S28-32. Kidney Int Suppl. 1991. PMID: 1881046 Review.
-
The pathophysiology of Sandimmune (cyclosporine) in man and animals.Pediatr Nephrol. 1990 Nov;4(6):686-704. doi: 10.1007/BF00858649. Pediatr Nephrol. 1990. PMID: 2088472 Review.
-
Cyclosporine nephrotoxicity: studies in laboratory animals.Transplant Proc. 1985 Aug;17(4 Suppl 1):145-54. Transplant Proc. 1985. PMID: 3895655 Review. No abstract available.
-
Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.J Hypertens. 1995 Sep;13(9):987-91. doi: 10.1097/00004872-199509000-00008. J Hypertens. 1995. PMID: 8586834 Clinical Trial.
-
Nephrotoxicity of cyclosporine in autoimmune diseases.Adv Nephrol Necker Hosp. 1990;19:169-85. Adv Nephrol Necker Hosp. 1990. PMID: 2105578 Review. No abstract available.
Cited by
-
Evaluating the effect of sulphated polysaccharides on cyclosporine a induced oxidative renal injury.Mol Cell Biochem. 2006 Jul;287(1-2):101-8. doi: 10.1007/s11010-005-9081-7. Epub 2006 May 16. Mol Cell Biochem. 2006. PMID: 16703458
-
Cellular signaling by cyclosporine A in contractile cells: interactions with atrial natriuretic peptide.Clin Investig. 1993 Feb;71(2):153-60. doi: 10.1007/BF00179998. Clin Investig. 1993. PMID: 8461628
-
Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat.Calcif Tissue Int. 1994 Oct;55(4):295-301. doi: 10.1007/BF00310409. Calcif Tissue Int. 1994. PMID: 7820781
-
Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?Yale J Biol Med. 1997 Jul-Aug;70(4):379-90. Yale J Biol Med. 1997. PMID: 9626758 Free PMC article.
-
Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients.Clin Investig. 1992 Aug;70(8):674-82. doi: 10.1007/BF00180284. Clin Investig. 1992. PMID: 1392444 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical